Features

Karen Dawes: A Closer Look
Karen DAWES A closer look By Taren Grom Marketing insights IN AN EXCLUSIVE INTERVIEW WITH PHARMAVOICE, KAREN DAWES PROVIDES INSIGHT TO THE CHALLENGES ASSOCIATED WITH TODAY’S MARKETING PRACTICES. 5 :30 a.m. is the start of a typical day for Karen A. Dawes, senior VP, marketing and sales for Bayer Pharmaceuticals USA. With responsibility for the [...]

By

Taren Grom, Editor

Unleashing the Power of Nexium
By Lynda Sears Unleashing the power of NEXIUM Taking the gastrointestinal market by storm, AstraZeneca follows up its own best in class proton pump inhibitor with a product that’s even better. ATTENTION PHYSICIANS AstraZeneca’s salesforce is in the field touting Nexium’s ability to eradicate heartburn symptoms, a big patient benefit Supported by overwhelming clinical success, [...]

By

Lynda Sears

CSOs: Not Just Hired Guns
Contract sales organizations have come a long way to stay one step ahead of their clients’ needs. Today, the contract sales industry is more than putting bodies in motion. No longer are contract sales organizations just “hired guns” employed for a temporary territory fix. Since 1995, when contract sales began to change from small, part-time [...]

By

Between Two Coasts
VIEW on Biotech Hoping to transform the rust belt into the Biotech belt, Michael Rosen, is spearheading an initiative to make the Midwest a mecca for biotech activity. IN AN EXCLUSIVE INTERVIEW WITH PHARMAVOICE, MICHAEL ROSEN,PRESIDENT AND CEO OF ENDOREX CORP. AND CO-CHAIRMAN OF THE BOARD OF THE CHICAGO BIOTECH NETWORK ASSOCIATION, DISCUSSES INITIATIVES TO [...]

By

A Piece of the Pie
Calling all marketers: don’t cancel those journal ads just yet, it may be time to evaluate the overall marketing mix for your brand’s promotion. Before brand managers and media directors make their next decision on how to divide up their promotional budget, they should consider the results of a comprehensive new study that measures return [...]

By

Making Investigators Top of Mind
Finding experienced and trained physician investigators will become more of a challenge in the future as new technologies and advances in genomics increase the number of drugs in development. 8,000 In just a few short years, this will be the projected short fall of clinical investigators. In fact, unless the industry starts to make the [...]